510(k) device
Elecsys Phospho-Tau (217P) Plasma
Roche Diagnostics · Immunoassay Blood Test For Amyloid Pathology Assessment (SET, Class II) · First FDA decision Oct 8, 2025, newest Aug 19, 2026Alzheimer's disease and dementia
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Elecsys Phospho-Tau Plasma"
MAUDE reports
0
Brand "Elecsys Phospho-Tau Plasma", since 2015
PubMed studies
0
Mentioning "Elecsys Phospho-Tau Plasma"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Elecsys Phospho-Tau (217P) Plasma
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 2 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Screening Immunoassay Fecal-Occult Blood TestNational analysisReview closedCAG-00180NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Elecsys Phospho-Tau Plasma", any status and sponsor, newest update first.
No registered device study names "Elecsys Phospho-Tau Plasma".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Elecsys Phospho-Tau Plasma", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SET
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Elecsys Phospho-Tau Plasma"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code SET.
- PrecivityAD2 TestC2N Diagnostics, LLC · 510(k) 2026
- Lumipulse G pTau217/ß-Amyloid 1-42 Plasma RatioFujirebio Diagnostics,Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.